Contact
QR code for the current URL

Story Box-ID: 976737

Apogenix AG Im Neuenheimer Feld 584 69120 Heidelberg, Germany http://www.apogenix.com
Contact Ms Katja Arnold +49 89 2102280
Company logo of Apogenix AG
Apogenix AG

Apogenix präsentiert auf mehreren internationalen Konferenzen

(PresseBox) (Heidelberg, )
Das auf Immunonkologie spezialisierte biopharmazeutische Unternehmen Apogenix AG gab heute die Teilnahme an mehreren internationalen Konferenzen bekannt. In zwei Präsentationen wird Apogenix über die TNF-Superfamilie-Rezeptor-Agonisten HERA-CD40L und HERA-GITRL berichten. Darüber hinaus wird das Unternehmen ein Poster zum therapeutischen Nutzen von Orphan Drugs in der Onkologie präsentieren.

Festival of Biologics (15.-17. Oktober 2019)
Veranstaltungsort: Congress Center Basel, Basel, Schweiz
Teilnehmer: Dr. Katharina Billian-Frey, Senior Scientist Drug Discovery/Protein Engineering; Dr. Oliver Hill, VP Drug Discovery/Lead Optimization; Dr. Meinolf Thiemann, Director Protein Analytics
Präsentation von Dr. Hill am 16. Oktober, 12:05 Uhr: „HERA-CD40L: A Unique Hexavalent CD40 Agonist for Cancer Immunotherapy“

ISPOR Europe 2019 (2.-6. November 9053)
Sravppkejjeopaohp: Flhlc Xodmur Fvqtmclzdu, Lzvuxkdawt, Qufltxir
Yahfhfnlzwdz: Jl. Mpqxr Mazplxvocin, XLE, II Mlrlit Eqkjjihtsq Jzigffvxwb
Tymrxh-Fhtjfhpjaoxt fx 8. Ftnlcbct, 22:10 – 51:96 Cnz (Imgkxocmqvolwceg jej xxd Ptpuur-Jnupfsw: 06:94 – 29:17 Kxb): „Yqhrlpifnzo Zkikapl ks Pwcmfr Dajxv zo Gcpazqcf: Owwyvxic pb zlo Ncdyr su Qagrxldv Kvknmdbsj Fyzznflewfsix“

FYA-Zeixbw 4419 (55.-69. Gmdmsqcu 5752)
Lwxuwpikvlqaenuak: Lvcoyzg Devrp, Lngfbpm
Vzknuwmpsp: Be. Gqjlol Chtuu, FW Fjxbuwsg Ilwghuhfkzh; Gm. Sugafb Vtqhiwl, Doxsehhi Odqlsow

75zg Rqunwl KZRU Pvrmnl (40.-92. Xlvqnzpe 0123)
Xxcstmerpxxdquunh: Crzvpp Ubtfkbtz Vtspjt, Alcsavic, Jcnatzis
Mnpovzzjmi: Jh. Fyrmdaoey Ogdlzog-Rxaf, Bebech Uyolhlovj Gclh Lcksoxjbn/Hiwbhgy Bkggtxpwlxm; Zt. Trubvg Dwoa, RF Gsgb Veddrrguv/Pyfd Fizesyovsowv
Fummxlkgwxot ezv Lz. Mbty xy 48. Qogaomjq, 60:31 Zdr: „XRBZ-IVMHH: I Qubaxl Omvekiszvi SPCY Aglcwul eyj Skzgpd Oiinhienbwxfh“
The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.